Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Orchestra BioMed Holdings (OBIO) Cost of Revenue (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Cost of Revenue for 4 consecutive years, with $51000.0 as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 12.07% to $51000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $190000.0 through Dec 2025, down 6.86% year-over-year, with the annual reading at $190000.0 for FY2025, 6.86% down from the prior year.
  • Cost of Revenue for Q4 2025 was $51000.0 at Orchestra BioMed Holdings, up from $49000.0 in the prior quarter.
  • The five-year high for Cost of Revenue was $68000.0 in Q3 2024, with the low at $34000.0 in Q1 2024.
  • Average Cost of Revenue over 4 years is $49437.5, with a median of $48000.0 recorded in 2023.
  • The sharpest move saw Cost of Revenue soared 65.85% in 2024, then decreased 27.94% in 2025.
  • Over 4 years, Cost of Revenue stood at $53000.0 in 2022, then decreased by 11.32% to $47000.0 in 2023, then grew by 23.4% to $58000.0 in 2024, then decreased by 12.07% to $51000.0 in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $51000.0, $49000.0, and $46000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.